Ginkgo Bioworks Holdings (DNA) Stock Statistics & Valuation Metrics

Ginkgo Bioworks Holdings has a market cap or net worth of $817.10M. The enterprise value is $674.10M.

Ginkgo Bioworks Holdings has 46,344,630 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ginkgo Bioworks Holdings’s return on equity (ROE) is -0.76 and return on invested capital (ROIC) is -43.05%.

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.

In the last 12 months, Ginkgo Bioworks Holdings had revenue of 227.04M and earned -547.03M in profits. Earnings per share was -10.54.

In the last 12 months, operating cash flow was -281.85M and capital expenditures -63.45M, giving a free cash flow of -345.30M billion.

Ginkgo Bioworks Holdings pays an annual dividend of ―, resulting in a dividend yield of ―

Ginkgo Bioworks Holdings upcoming earnings date is Aug 19, 2025, After Close (Confirmed).

Ginkgo Bioworks Holdings as a current ratio of 5.62, with Debt / Equity ratio of 67.12%

In the past 12 months, Ginkgo Bioworks Holdings has paid -479.00K in taxes.

Ginkgo Bioworks Holdings EV to EBITDA ratio is -0.86, with an EV/FCF ratio of -1.09.

Ginkgo Bioworks Holdings has $516.92M in cash and marketable securities with $434.56M in debt, giving a net cash position of -$82.36M billion.

Gross margin is 73.59%, with operating margin of -246.54%, and net profit margin of -240.94%.

The average price target for Ginkgo Bioworks Holdings is $9.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell